115
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Aspirin Ameliorates Pancreatic Inflammation and Fibrosis by Inhibiting COX-2 Expression in Experimental Chronic Pancreatitis

, , , , , , , & show all
Pages 4737-4749 | Published online: 19 Aug 2022

References

  • Whitcomb DC, Shimosegawa T, Chari ST. International consensus statements on early chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Panc. Pancreatology. 2018;18(5):516–527. doi:10.1016/j.pan.2018.05.008
  • Beyer G, Habtezion A, Werner J, Lerch MM, Mayerle J. Chronic pancreatitis. Lancet. 2020;396(10249):499–512. doi:10.1016/S0140-6736(20)31318-0
  • Schlosser W, Schlosser S, Ramadani M, Gansauge F, Gansauge S, Beger H-G. Cyclooxygenase-2 is overexpressed in chronic pancreatitis. Pancreas. 2002;25(1):26–30. doi:10.1097/00006676-200207000-00008
  • Koliopanos A, Friess H, Kleeff JO, et al. Cyclooxygenase 2 expression in chronic pancreatitis: correlation with stage of the disease and diabetes mellitus. Digestion. 2001;64(4):240–247. doi:10.1159/000048868
  • Koh YC, Liu SY, Wu JC, Chou YC, Pan MH. A new metabolite: the effects of aminated tetrahydrocurcumin on inducible nitric oxide synthase and cyclooxygenase-2. J Cancer Res Pract. 2021;8(2):41. doi:10.4103/JCRP.JCRP_21_20
  • Ahmed M, Hussain AR, Siraj AK. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells. Mol Cancer. 2015;14(1):131. doi:10.1186/s12943-015-0406-1
  • Reding T, Bimmler D, Perren A, et al. A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis. Gut. 2006;55(8):1165–1173.
  • Huang H, Chen J, Peng L. Transgenic expression of cyclooxygenase-2 in pancreatic acinar cells induces chronic pancreatitis. Am J Physiol. 2019;316(1):G179–G186. doi:10.1152/ajpgi.00096.2018
  • Wu KK. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin Vasc Med. 2003;03(2):107–112. doi:10.1055/s-2003-40668
  • Vane JR, Botting RM. Mechanism of action of aspirin-like drugs. Semin Arthritis Rheu. 1997;26:2–10. doi:10.1016/S0049-0172(97)80046-7
  • Akyazi I, Eraslan E, Gülçubuk A. Long-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in rats. World J Gastroentero. 2013;19(19):2894–2903. doi:10.3748/wjg.v19.i19.2894
  • Lu G, Tong Z, Ding Y, et al. Aspirin protects against acinar cells necrosis in severe acute pancreatitis in mice. Biomed Res Int. 2016;2016:1–10. doi:10.1155/2016/6089430
  • Bosetti C, Santucci C, Gallus S, Martinetti M, La Vecchia C. Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019. Ann Oncol. 2020;31(5):558–568. doi:10.1016/j.annonc.2020.02.012
  • Jiang W, Yan Y, Chen M. Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter. Aging. 2020;12(1):611–627. doi:10.18632/aging.102644
  • Alfonso L, Ai G, Spitale RC, Bhat GJ. Molecular targets of aspirin and cancer prevention. Brit J Cancer. 2014;111(1):61–67. doi:10.1038/bjc.2014.271
  • Mohammed A, Madka V, Kumar G, Singh A, Rao CV. Abstract 13: aspirin and metformin combination inhibits PDAC progression and metastasis in KPC mice. Paper presented at: Proceedings: AACR Annual Meeting 2020; April 27–28, 2020 and June 22–24, 2020; 2020; Philadelphia, PA.
  • Habtezion A. Inflammation in acute and chronic pancreatitis. Curr Opin Gastroen. 2015;31(5):395–399. doi:10.1097/MOG.0000000000000195
  • Korpela T, Udd M, Mustonen H. Association between chronic pancreatitis and pancreatic cancer: a 10-year retrospective study of endoscopically treated and surgical patients. Int J Cancer. 2020;147(5):1450–1460. doi:10.1002/ijc.32971
  • Garg SK, Dawra R, Barlass U, Yuan Z, Dixit AK, Saluja A. Sa1792 development of a new mouse model of chronic pancreatitis induced by administration of L-arginine. Gastroenterology. 2014;146(5):297. doi:10.1016/S0016-5085(14)61062-3
  • Niina Y, Ito T, Oono T, et al. A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Pancreatology. 2014;14(3):201–210. doi:10.1016/j.pan.2014.02.009
  • Gukovskaya AS, Gukovsky I, Algül H, Habtezion A. Autophagy, inflammation, and immune dysfunction in the pathogenesis of pancreatitis. Gastroenterology. 2017;153(5):1212–1226. doi:10.1053/j.gastro.2017.08.071
  • Zannikou M, Barbayianni I, Fanidis D, Grigorakaki T, Aidinis V. MAP3K8 regulates Cox-2–mediated prostaglandin E 2 production in the lung and suppresses pulmonary inflammation and fibrosis. J Immunol. 2020;206(3):i2000862. doi:10.4049/JIMMUNOL.2000862
  • Yu J, Hui AY, Chu ESH. Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis. Gut. 2007;56(7):991–999. doi:10.1136/gut.2006.097923
  • Silva A, Weber A, Bain M, Reding T, Graf R. COX-2 is not required for the development of murine chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2011;300(6):G968. doi:10.1152/ajpgi.00497.2010
  • Espinosa E, Murad JP, Khasawneh FT. Aspirin: pharmacology and clinical applications. Thrombosis. 2011;2012(5):173124. doi:10.1155/2012/173124
  • Kleeff J, Whitcomb DC, Shimosegawa T, et al. Chronic pancreatitis. Nat Rev Dis Primers. 2017;3(1):17060. doi:10.1038/nrdp.2017.60
  • Yadav Dhiraj OMPG, O’Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol. 2012;107(7):1096–1103. doi:10.1038/ajg.2012.126
  • Geisz A, Sahin-Tóth M. Sentinel acute pancreatitis event (SAPE) increases severity of subsequent episodes in mice. Gastroenterology. 2021;161(5):1692–1694. doi:10.1053/j.gastro.2021.06.013
  • Li-Fang D, Fan X, et al. Dachaihu decoction ameliorates pancreatic fibrosis by inhibiting macrophage infiltration in chronic pancreatitis. World J Gastroentero. 2017;23(40):7242. doi:10.3748/wjg.v23.i40.7242